Skip to content
Trial Eligibility
Menu

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE

NCT05909046

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

DIP : To conduct a pragmatic, non-blinded randomized controlled trial (pRCT) of immediate in-patient postpartum OGTT prior to delivery discharge (intervention) versus 4-12 week outpatient postpartum OGTT (current standard care) to improve the frequency of post-partum diabetes screening among individuals with a pregnancy complicated by GDM.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Pre-Gestational Diabetes
  • Type2diabetes
  • Pregnancy in Diabetic
  • Pregnancy, High Risk
  • Gestational Diabetes
  • Gestational Diabetes Mellitus in the Puerperium

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
Female
Healthy volunteers
Not accepted
Sponsor
Ohio State University
Last updated on ClinicalTrials.gov
September 29, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Ohio · 1

  • The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine · Columbus, OH

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.